)
SES AI (SES) investor relations material
SES AI Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Charge, Fly and Discover link energy storage, drone cells and Molecular Universe; drone and unmanned-system cells are the central growth priority.
Q3 revenue was $6.640 million, up 31% QoQ; GAAP and non-GAAP losses narrowed QoQ, and FY 2026 revenue guidance was reiterated at $30 million to $35 million.
Financial highlights
Q3 revenue was $6.640 million versus $5.072 million in Q2 and $7.118 million a year earlier; nine-month revenue was $18.423 million versus $16.438 million.
Q3 GAAP net loss was $13.380 million, or $0.04 per share, versus $17.905 million, or $0.05 per share, in Q2; nine-month net loss was $43.391 million.
Q3 non-GAAP net loss was $10.7 million, or $0.03 per share, versus $13.1 million, or $0.04 per share, in Q2; Adjusted EBITDA loss was $12.0 million versus $14.6 million.
GAAP operating expenses were $18.745 million, down from $20.343 million QoQ; Q3 gross profit was $0.327 million versus $3.636 million a year earlier.
Q3 gross margin was 4.9% versus 22.6% in Q2, mainly reflecting lower-margin sales of older energy storage hardware inventory during product upgrades.
Outlook and guidance
FY 2026 revenue guidance was reiterated at $30 million to $35 million; nine-month revenue of $18.423 million implies Q4 revenue of $11.577 million to $16.577 million.
Q4 growth expectations include seasonal ESS demand and drone orders from Drone Dominance Program Gauntlet participants; orders began arriving in October and November.
Drone shipments are expected to rise from thousands of cells in Q4 to tens of thousands starting Q1; most orders can be built and delivered in the same quarter.
Expansion from 1 million to 3 million annual NDAA-compliant cells is targeted by end-Q2 2027; qualified 2027 output is targeted at 1 million to 1.5 million cells.
Cash and marketable securities are expected to fund principal working capital, capex, R&D, operations and commercial activity for at least 12 months from the report date.
- Five proposals put NYSE listing, officer liability and executive pay before stockholders.SES
Proxy filing - Board backs all five proposals, including a 5:1 to 20:1 reverse split.SES
Proxy filing - Five proposals center on NYSE-listing flexibility and expanded officer exculpation.SES
Proxy filing - B-Sample development advances toward 2027 commercialization amid losses and rising investment.SES
Q4 2023 - Q2 2026 revenue rose 44% to $5.1M, margin improved, but net loss and legal risks remain.SES
Q2 2026 - Shelf registration allows up to $300M in offerings, including $150M ATM equity sales.SES
Registration filing - Q1 2026 revenue up 47% sequentially to $6.7M, led by ESS, with guidance reaffirmed.SES
Q1 2026 - Q3 revenue rose 102% to $7.1M, with strong AI, ESS, and SaaS growth, but risks persist.SES
Q3 2025 - Record Q1 revenue of $5.8M, high margins, $30M buyback, and new platform launch ahead.SES
Q1 2025
)
)
)
)
)
)
)
)